Guidelines Part 8: ACLS Writing Group Disclosures

Writing Group MemberEmploymentResearch GrantOther Research SupportSpeakers' Bureau/ HonorariaOwnership InterestConsultant/ Advisory BoardOther
Robert W. NeumarUniversity of Pennsylvania-Associate Professor of Emergency MedicineNoneNoneNoneNoneNoneNone
Charles W. OttoUniversity of Arizona– ProfessorNoneNoneNoneNoneNoneNone
Mark S. LinkTufts Medical Center– PhysicianNoneNoneNoneNoneNoneNone
Steven L. KronickUniversity of Michigan–Assistant ProfessorNoneNoneNoneNoneNoneNone
Michael ShusterSelf-employed–emergency physicianNoneNoneNoneNoneNoneNone
Clifton W. CallawayUniversity of Pittsburgh School of Medicine–Associate Professor; UPMC Health System—Physician *American Heart Association-Work Sheet Editor for 2010 Guidelines. My effort on this project is paid to University of Pittsburgh as a “contracted services agreement,” and not paid directly to meGrants to University of Pittsburgh: NHLBI-Resuscitation Outcomes Consortium HRSA-Development and Dissemination of Program Tools for Uncontrolled Donation After Cardiac Death (UDCD)*Loan of an Arctic Sun cooling device (without disposables) to human physiology laboratory for experiments on hypothermia by Medivance, Inc.NoneCo-inventor on patent about ventricular fibrillation waveform analysis, licensed by University of Pittsburgh to Medtronic ERS, Inc.NoneNone
Peter J. KudenchukUniversity of Washington–Professor of MedicineResuscitation Outcomes Consortium (NIH/NHLBI)NoneNetwork for Continuing Medical Education, Academy for Healthcare Education, Sanofi-Aventis, with honorariaSanofi-Aventis, NovartisNoneNone
Joseph P. OrnatoRichmond Ambulance Authority–Medical Director; Virginia Commonwealth University-Prof & Chmn, Emergency MedicineConsultant and Cardiac Co-Chairman, NIH Resuscitation Outcomes Consortium Principal Investigator, VCU site for NIH Neurological Emergency Treatment Trials NetworkNone*Hospital grand rounds presentations funded by ZOLL Circulation *Occasional hospital grand rounds supported by unrestricted educational grants from Squibb/Sanofi, ZOLLNone*ZOLL Circulation Science Advisory Board (UNPAID, only receive travel reimbursement)None
Bryan McNallyEmory University– Assistant Professor of Emergency MedicineCenter for Disease Control and Prevention, CARES-Cardiac Arrest Registry to Enhance Survival, Money comes to Emory University School of Medicine as part of a cooperative agreement through American Association of Medical CollegesNoneNoneNoneNoneNone
Scott M. SilversMayo Clinic–Chair, Department of Emergency MedicineNoneNoneNoneNoneNoneNone
Rod S. PassmanNorthwestern University–Associate ProfessorNoneNoneNoneNone*Steering Committee member for Medtronic Crystal AF studyNone
Roger D. WhiteMayo Clinic–staff physicianNoneNoneNoneNoneNoneNone
Erik P. HessMayo Clinic–Senior Associate ConsultantNoneNoneNoneNoneNoneNone
Wanchun TangWeil Institute of Critical Care Medicine–Professor and presidentNoneNone*47th Weil Critical Care Symposium: $1,500NoneNoneNone
Daniel DavisUC San Diego–Faculty physicianZoll Medical (Air Medical Advanced Monitoring Strategies)*Bispectral EEG Analyzer (Zoll Medical)*Continuous Renal Replacement Therapy Conference 2009 Hospital Medicine National and Regional Meeting 2009 Grand Rounds Redding Medical CenterNoneCardinal Health (Development of a Prehospital Ventilator)*Derek White Law Firm John Anderson Law Firm Otorowski Johnston Diamond & Golden Law Firm
Elizabeth SinzPenn State Hershey Medical Center–Professor of Anesthesiology and Neurosurgery; AHA: Paid Consultant Associate Science EditorNoneNoneNoneNoneNoneNone
Laurie J. MorrisonSt Michaels Hosp. Clinician ScientistNoneNoneNoneNoneNoneNone
  • This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

  • * Modest.

  • Significant.